RBOT vs. LFWD, MLSS, NTRB, COCH, CLGN, IMRX, ADEX, ABIO, BHG, and LUCD
Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include ReWalk Robotics (LFWD), Milestone Scientific (MLSS), Nutriband (NTRB), Envoy Medical (COCH), CollPlant Biotechnologies (CLGN), Immuneering (IMRX), Adit EdTech Acquisition (ADEX), ARCA biopharma (ABIO), Bright Health Group (BHG), and Lucid Diagnostics (LUCD). These companies are all part of the "medical" sector.
ReWalk Robotics (NASDAQ:LFWD) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, community ranking, profitability, earnings, risk, media sentiment, institutional ownership and valuation.
Vicarious Surgical has a net margin of 0.00% compared to Vicarious Surgical's net margin of -159.76%. Vicarious Surgical's return on equity of -28.19% beat ReWalk Robotics' return on equity.
ReWalk Robotics has higher revenue and earnings than Vicarious Surgical. ReWalk Robotics is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
ReWalk Robotics has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500.
Vicarious Surgical received 5 more outperform votes than ReWalk Robotics when rated by MarketBeat users. However, 100.00% of users gave ReWalk Robotics an outperform vote while only 38.10% of users gave Vicarious Surgical an outperform vote.
ReWalk Robotics presently has a consensus price target of $13.00, indicating a potential upside of 156.92%. Vicarious Surgical has a consensus price target of $0.67, indicating a potential upside of 101.96%. Given Vicarious Surgical's stronger consensus rating and higher probable upside, equities analysts plainly believe ReWalk Robotics is more favorable than Vicarious Surgical.
In the previous week, ReWalk Robotics had 9 more articles in the media than Vicarious Surgical. MarketBeat recorded 9 mentions for ReWalk Robotics and 0 mentions for Vicarious Surgical. Vicarious Surgical's average media sentiment score of 0.16 beat ReWalk Robotics' score of 0.00 indicating that ReWalk Robotics is being referred to more favorably in the media.
26.8% of ReWalk Robotics shares are held by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are held by institutional investors. 2.1% of ReWalk Robotics shares are held by insiders. Comparatively, 11.7% of Vicarious Surgical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
ReWalk Robotics beats Vicarious Surgical on 11 of the 17 factors compared between the two stocks.
Get Vicarious Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vicarious Surgical Competitors List
Related Companies and Tools
